Adaptive Biotechnologies Corp. (ADPT)
28.35
+0.98
(+3.58%)
USD |
NASDAQ |
Oct 02, 16:00
28.34
-0.02
(-0.05%)
Pre-Market: 20:00
Adaptive Biotechnologies Price to Book Value : 31.55 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 31.55 |
| October 01, 2026 | 30.46 |
| September 30, 2026 | 32.17 |
| September 29, 2026 | 32.02 |
| September 28, 2026 | 31.73 |
| September 25, 2026 | 32.75 |
| September 24, 2026 | 32.91 |
| September 23, 2026 | 31.04 |
| September 22, 2026 | 31.23 |
| September 21, 2026 | 31.01 |
| September 18, 2026 | 31.84 |
| September 17, 2026 | 31.78 |
| September 16, 2026 | 30.80 |
| September 15, 2026 | 29.69 |
| September 14, 2026 | 27.58 |
| September 11, 2026 | 26.93 |
| September 10, 2026 | 26.97 |
| September 09, 2026 | 27.18 |
| September 08, 2026 | 27.09 |
| September 04, 2026 | 27.02 |
| September 03, 2026 | 27.35 |
| September 02, 2026 | 27.45 |
| September 01, 2026 | 27.09 |
| August 31, 2026 | 27.74 |
| August 28, 2026 | 28.04 |
| Date | Value |
|---|---|
| August 27, 2026 | 29.43 |
| August 26, 2026 | 29.12 |
| August 25, 2026 | 29.22 |
| August 24, 2026 | 28.44 |
| August 21, 2026 | 28.93 |
| August 20, 2026 | 28.31 |
| August 19, 2026 | 28.37 |
| August 18, 2026 | 27.33 |
| August 17, 2026 | 27.57 |
| August 14, 2026 | 27.54 |
| August 13, 2026 | 27.22 |
| August 12, 2026 | 28.10 |
| August 11, 2026 | 28.26 |
| August 10, 2026 | 28.33 |
| August 07, 2026 | 27.75 |
| August 06, 2026 | 26.27 |
| August 05, 2026 | 27.38 |
| August 04, 2026 | 27.32 |
| August 03, 2026 | 25.72 |
| July 31, 2026 | 25.12 |
| July 30, 2026 | 26.91 |
| July 29, 2026 | 25.11 |
| July 28, 2026 | 25.06 |
| July 27, 2026 | 25.09 |
| July 24, 2026 | 24.79 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Personalis, Inc. | 7.364 |
| 10X Genomics, Inc. | 14.76 |
| Alamar Biosciences, Inc. (California) | 7.621 |
| Champions Oncology, Inc. | 17.66 |
| Medpace Holdings, Inc. | 38.47 |
Price to Book Value Related Metrics
| PS Ratio | 14.53 |
| Price | 28.35 |
| Earnings Yield | -1.44% |
| Market Cap | 4.509B |